Concepedia

Amplyx Pharmaceuticals (United States)

AP

Statistics

Publications

308

Citations

78.7K

Authors

109

Location

San Diego, United States

Amplyx Pharmaceuticals (United States) is a company institution in San Diego, United States known for medicine, pharmacology, and endocrinology.

HomepageROR

Top concepts

Publications

308

Effects of Exenatide (Exendin-4) on Glycemic Control and Weight Over 30 Weeks in Metformin-Treated Patients With Type 2 Diabetes

Ralph A. DeFronzo, Robert E. Ratner, Jenny Han et al. · Diabetes Care · 2005 · 1.6K citations

, , +11

Effects of Exenatide (Exendin-4) on Glycemic Control Over 30 Weeks in Sulfonylurea-Treated Patients With Type 2 Diabetes

John B. Buse, Robert R. Henry, Jenny Han et al. · Diabetes Care · 2004 · 1.3K citations · Full text

, , +14

Effects of Exenatide (Exendin-4) on Glycemic Control Over 30 Weeks in Patients With Type 2 Diabetes Treated With Metformin and a Sulfonylurea

David M. Kendall, Matthew C. Riddle, Julio Rosenstock et al. · Diabetes Care · 2005 · 1.2K citations · Full text

, , +17

Activation of Raf as a Result of Recruitment to the Plasma Membrane

David Stokoe, Susan G. Macdonald, Karen A. Cadwallader et al. · Science · 1994 · 985 citations

, , +15

ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents

Carla Heise, Adam Sampson-Johannes, Angelica Williams et al. · Nature Medicine · 1997 · 947 citations

, , +13

1–5 of 308

Authors

109

  1. DG
    David G. Parkes

    Amplyx Pharmaceuticals (United States), United States

    141 publications · 7.7K citations

    47

    h-index

  2. AA
    Andrew A. Young

    Amplyx Pharmaceuticals (United States), United States

    83 publications · 6.6K citations

    42

    h-index

  3. DM
    David Maggs

    Amplyx Pharmaceuticals (United States), United States

    106 publications · 7K citations

    41

    h-index

  4. MF
    Mark Fineman

    Amplyx Pharmaceuticals (United States), United States

    74 publications · 11.3K citations

    39

    h-index

  5. MR
    Michael R. Hodges

    Amplyx Pharmaceuticals (United States), United States

    84 publications · 8.4K citations

    28

    h-index

1–5 of 109